Utilization and Safety of the Mk II Inserter and the Safety of the FAI Insert in Non-Infectious Uveitis
Status:
Completed
Trial end date:
2017-08-17
Target enrollment:
Participant gender:
Summary
This trial is a 12 month, Phase 3, multi-center, randomized, single-masked (subject),
controlled study designed to evaluate the utilization and safety of the Mk II inserter and
the safety of the FAI insert, in subjects with non-infectious uveitis affecting the posterior
segment of the eye.